Avantor (AVTR) Shares Outstanding (Weighted Average) (2017 - 2026)
Avantor (AVTR) recorded quarterly Shares Outstanding (Weighted Average) of $675.7 million in Q1 2026, down 0.72% quarter-over-quarter from $680.6 million in Q4 2025, and down 0.79% on a YoY basis from $681.1 million in Q1 2025.
Avantor (AVTR) Shares Outstanding (Weighted Average) (2017 - 2026) Analysis & Trends
Avantor's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $675.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 0.79% year-over-year to $675.7 million; the TTM figure through Mar 2026 stood at $675.7 million (down 0.79% YoY), while the FY2025 annual figure was $680.6 million, changed 0.15% from the prior year.
- Shares Outstanding (Weighted Average) was $675.7 million for Q1 2026 at Avantor, down from $680.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $681.4 million in Q3 2025 to a low of $610.1 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $669.4 million across 5 years, with a median of $676.0 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) climbed 14.55% in 2022, then slipped 0.79% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $650.9 million in 2022, then advanced by 3.79% to $675.6 million in 2023, then rose by 0.59% to $679.6 million in 2024, then increased by 0.15% to $680.6 million in 2025, then dropped by 0.72% to $675.7 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $675.7 million (Q1 2026), $680.6 million (Q4 2025), and $681.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | 675.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 675.70 Mn |
| Dec 31, 2025 | 680.60 Mn |
| Sep 30, 2025 | 681.40 Mn |
| Jun 30, 2025 | 681.30 Mn |
| Mar 31, 2025 | 681.10 Mn |
| Dec 31, 2024 | 679.60 Mn |
| Sep 30, 2024 | 679.30 Mn |
| Jun 30, 2024 | 678.70 Mn |
| Mar 31, 2024 | 678.10 Mn |
| Dec 31, 2023 | 675.60 Mn |
| Sep 30, 2023 | 676.00 Mn |
| Jun 30, 2023 | 675.30 Mn |
| Mar 31, 2023 | 674.70 Mn |
| Dec 31, 2022 | 650.90 Mn |
| Sep 30, 2022 | 674.10 Mn |
| Jun 30, 2022 | 627.20 Mn |
| Mar 31, 2022 | 610.10 Mn |
| Dec 31, 2021 | 590.50 Mn |
| Sep 30, 2021 | 588.50 Mn |
| Jun 30, 2021 | 582.60 Mn |